Home > Report on the risk assessment of N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Report on the risk assessment of N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 50 p.

[img]
Preview
PDF (Acryloylfentanyl)
929kB

EMCDDA Risk Assessments are publications examining the health and social risks of individual new psychoactive substances.

This publication presents the data and findings of the risk assessment on N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 25 September 2017, the Council decided that acryloylfentanyl should be subject to control measures across the Member States.

Acryloylfentanyl is known from the scientific literature and is a close structural relative of fentanyl. Fentanyl is a fast but short-acting synthetic opioid.

Table of contents:
• EMCDDA actions on monitoring and responding to new drugs
• EMCDDA–Europol Joint Report on acryloylfentanyl: a summary
• Risk Assessment Report of a new psychoactive substance: acryloylfentanyl
• Annex 1: Technical report on acryloylfentanyl
• Council Decision on subjecting acryloylfentanyl to control measures
• Participants of the risk assessment meeting


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Opioid, New psychoactive substance
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:5 December 2017
Pages:50 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Related URLs:
Subjects:B Drugs and alcohol substances > New (novel) psychoactive substances
J Health care, prevention and rehabilitation > Risk and needs assessment > Risk assessment
J Health care, prevention and rehabilitation > Drugs and alcohol prevention > Drugs and alcohol use harm reduction
VA Geographic area > Europe

Repository Staff Only: item control page